SARAH YESKEL: Open Payments
NPI 1760700579 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 39 payments from 11 companies in 2025. Trend: 2023 $829 · 2024 $930 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $273 |
| ABBVIE INC. | 15 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Gilead Sciences, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: TREMFYA, CREON, ENTYVIO, MAVYRET, VELSIPITY, DUPIXENT, LINZESS, OMVOH.
Industry payments across GA — which companies pay providers there.
